X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8) 8
humans (7) 7
male (6) 6
adult (4) 4
aged (4) 4
aged, 80 and over (4) 4
female (4) 4
metastasis (4) 4
middle aged (4) 4
analysis (3) 3
antineoplastic agents - therapeutic use (3) 3
cancer (3) 3
carcinoma, renal cell - drug therapy (3) 3
chemotherapy (3) 3
medical prognosis (3) 3
patients (3) 3
treatment outcome (3) 3
tumors (3) 3
urology (3) 3
urology & nephrology (3) 3
abridged index medicus (2) 2
antibodies, monoclonal - therapeutic use (2) 2
biopsy (2) 2
carcinoma, renal cell (2) 2
care and treatment (2) 2
clinical medicine (2) 2
combined modality therapy - methods (2) 2
combined modality therapy - standards (2) 2
consensus (2) 2
consensus development conferences as topic (2) 2
europe (2) 2
indoles - therapeutic use (2) 2
kidney neoplasms - drug therapy (2) 2
klinisk medicin (2) 2
long-term survivors (2) 2
lung cancer (2) 2
lymph-node dissection (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
neoplasm staging (2) 2
neoplasm staging - methods (2) 2
neoplasm staging - standards (2) 2
neoplasms, germ cell and embryonal - diagnosis (2) 2
neoplasms, germ cell and embryonal - therapy (2) 2
oncology (2) 2
positron-emission-tomography (2) 2
practice guidelines as topic (2) 2
prognosis (2) 2
prognostic-factors (2) 2
pyrroles - therapeutic use (2) 2
sirolimus - analogs & derivatives (2) 2
sirolimus - therapeutic use (2) 2
societies, medical (2) 2
studies (2) 2
sunitinib (2) 2
surgery (2) 2
survival (2) 2
survival analysis (2) 2
testicular neoplasms - diagnosis (2) 2
testicular neoplasms - therapy (2) 2
urologi och njurmedicin (2) 2
urologic and male genital diseases (2) 2
urology and nephrology (2) 2
vascular endothelial growth factor (2) 2
1st-line everolimus (1) 1
[ sdv.ot ] life sciences [q-bio]/other [q-bio.ot] (1) 1
adjuvant chemotherapy (1) 1
adolescent (1) 1
afatinib (1) 1
anti-programmed death-1 (1) 1
antibodies, monoclonal (1) 1
antibodies, monoclonal - adverse effects (1) 1
antineoplastic agents (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - blood (1) 1
antineoplastic agents - pharmacokinetics (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
apoptosis (1) 1
article (1) 1
atp binding cassette transporter, subfamily b - genetics (1) 1
axitinib (1) 1
b7-h1 (1) 1
biomarker (1) 1
biomarkers (1) 1
body weight (1) 1
carcinoma (1) 1
carcinoma, large cell - mortality (1) 1
carcinoma, large cell - pathology (1) 1
carcinoma, large cell - surgery (1) 1
carcinoma, neuroendocrine - mortality (1) 1
carcinoma, neuroendocrine - pathology (1) 1
carcinoma, neuroendocrine - surgery (1) 1
carcinoma, renal cell - blood (1) 1
carcinoma, renal cell - genetics (1) 1
carcinoma, renal cell - mortality (1) 1
carcinoma, squamous cell - drug therapy (1) 1
cardiac & cardiovascular systems (1) 1
cardiothoracic surgery (1) 1
cell survival (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 583 - 594
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1803 - 1813
Journal Article
by Krege, Susanne and Beyer, Jörg and Souchon, Rainer and Albers, Peter and Albrecht, Walter and Algaba, Ferran and Bamberg, Michael and Bodrogi, István and Bokemeyer, Carsten and Cavallin-Ståhl, Eva and Classen, Johannes and Clemm, Christoph and Cohn-Cedermark, Gabriella and Culine, Stéphane and Daugaard, Gedske and De Mulder, Pieter H.M and De Santis, Maria and de Wit, Maike and de Wit, Ronald and Derigs, Hans Günter and Dieckmann, Klaus-Peter and Dieing, Annette and Droz, Jean-Pierre and Fenner, Martin and Fizazi, Karim and Flechon, Aude and Fosså, Sophie D and Garcia del Muro, Xavier and Gauler, Thomas and Geczi, Lajos and Gerl, Arthur and Germa-Lluch, Jose Ramon and Gillessen, Silke and Hartmann, Jörg T and Hartmann, Michael and Heidenreich, Axel and Hoeltl, Wolfgang and Horwich, Alan and Huddart, Robert and Jewett, Michael and Joffe, Johnathan and Jones, William G and Kisbenedek, László and Klepp, Olbjørn and Kliesch, Sabine and Koehrmann, Kai Uwe and Kollmannsberger, Christian and Kuczyk, Markus and Laguna, Pilar and Leiva Galvis, Oscar and Loy, Volker and Mason, Malcolm D and Mead, Graham M and Mueller, Rolf and Nichols, Craig and Nicolai, Nicola and Oliver, Tim and Ondrus, Dalibor and Oosterhof, Gosse O.N and Paz Ares, Luis and Pizzocaro, Giorgio and Pont, Jörg and Pottek, Tobias and Powles, Tom and Rick, Oliver and Rosti, Giovanni and Salvioni, Roberto and Scheiderbauer, Jutta and Schmelz, Hans-Ulrich and Schmidberger, Heinz and Schmoll, Hans-Joachim and Schrader, Mark and Sedlmayer, Felix and Skakkebaek, Niels E and Sohaib, Aslam and Tjulandin, Sergei and Warde, Padraig and Weinknecht, Stefan and Weissbach, Lothar and Wittekind, Christian and Winter, Eva and Wood, Lori and von der Maase, Hans and Onkologi och Patologi, MV and Lund University and Oncology and Pathology, MV and Lunds universitet
European Urology, ISSN 0302-2838, 2007, Volume 53, Issue 3, pp. 478 - 496
Journal Article
by Krege, Susanne and Beyer, Jörg and Souchon, Rainer and Albers, Peter and Albrecht, Walter and Algaba, Ferran and Bamberg, Michael and Bodrogi, István and Bokemeyer, Carsten and Cavallin-Ståhl, Eva and Classen, Johannes and Clemm, Christoph and Cohn-Cedermark, Gabriella and Culine, Stéphane and Daugaard, Gedske and De Mulder, Pieter H.M and De Santis, Maria and de Wit, Maike and de Wit, Ronald and Derigs, Hans Günter and Dieckmann, Klaus-Peter and Dieing, Annette and Droz, Jean-Pierre and Fenner, Martin and Fizazi, Karim and Flechon, Aude and Fosså, Sophie D and Garcia del Muro, Xavier and Gauler, Thomas and Geczi, Lajos and Gerl, Arthur and Germa-Lluch, Jose Ramon and Gillessen, Silke and Hartmann, Jörg T and Hartmann, Michael and Heidenreich, Axel and Hoeltl, Wolfgang and Horwich, Alan and Huddart, Robert and Jewett, Michael and Joffe, Johnathan and Jones, William G and Kisbenedek, László and Klepp, Olbjørn and Kliesch, Sabine and Koehrmann, Kai Uwe and Kollmannsberger, Christian and Kuczyk, Markus and Laguna, Pilar and Leiva Galvis, Oscar and Loy, Volker and Mason, Malcolm D and Mead, Graham M and Mueller, Rolf and Nichols, Craig and Nicolai, Nicola and Oliver, Tim and Ondrus, Dalibor and Oosterhof, Gosse O.N and Paz-Ares, Luis and Pizzocaro, Giorgio and Pont, Jörg and Pottek, Tobias and Powles, Tom and Rick, Oliver and Rosti, Giovanni and Salvioni, Roberto and Scheiderbauer, Jutta and Schmelz, Hans-Ulrich and Schmidberger, Heinz and Schmoll, Hans-Joachim and Schrader, Mark and Sedlmayer, Felix and Skakkebaek, Niels E and Sohaib, Aslam and Tjulandin, Sergei and Warde, Padraig and Weinknecht, Stefan and Weissbach, Lothar and Wittekind, Christian and Winter, Eva and Wood, Lori and von der Maase, Hans and Onkologi och Patologi, MV and Lund University and Oncology and Pathology, MV and Lunds universitet
European Urology, ISSN 0302-2838, 2007, Volume 53, Issue 3, pp. 497 - 513
Journal Article
Nature Reviews Urology, ISSN 1759-4812, 08/2018, Volume 15, Issue 8, pp. 511 - 521
Bone is a major site of haematogenous tumour cell spread in renal cell carcinoma (RCC), and most patients with RCC will develop painful and functionally... 
Glycoproteins | Metastasis | Interdisciplinary aspects | Medical prognosis
Journal Article
Cpt Pharmacometrics and Systems Pharmacology, ISSN 2163-8306, 2017, Volume 6, Issue 9, pp. 604 - 613
The tyrosine kinase inhibitor sunitinib is used as first-line therapy in patients with metastasized renal cell carcinoma (mRCC), given in fixed-dose regimens... 
Interleukin-8 - genetics | Kidney Neoplasms - genetics | Pyrroles - pharmacokinetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Carcinoma, Renal Cell - genetics | Male | Antineoplastic Agents - therapeutic use | Vascular Endothelial Growth Factor A - genetics | Kidney Neoplasms - blood | Vascular Endothelial Growth Factor Receptor-2 - genetics | Sunitinib | Cytochrome P-450 CYP3A - genetics | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Indoles - pharmacology | ATP Binding Cassette Transporter, Subfamily B - genetics | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Protein Kinase Inhibitors - pharmacokinetics | Carcinoma, Renal Cell - blood | Colorectal Neoplasms - blood | Indoles - blood | Vascular Endothelial Growth Factor Receptor-2 - blood | Genotype | Treatment Outcome | Pyrroles - blood | Vascular Endothelial Growth Factor Receptor-3 - blood | Protein Kinase Inhibitors - blood | Pyrroles - pharmacology | Models, Biological | Protein Kinase Inhibitors - therapeutic use | Antineoplastic Agents - blood | Indoles - pharmacokinetics | Indoles - therapeutic use | Aged | Polymorphism, Single Nucleotide | Protein Kinase Inhibitors - pharmacology | Kidney Neoplasms - drug therapy | Vascular Endothelial Growth Factor Receptor-3 - genetics | Studies | Colorectal cancer | Biomarkers | Patients | Vascular endothelial growth factor | Drug dosages | Clinical outcomes | Tumors | Index Medicus | Original
Journal Article
Oncology, ISSN 0030-2414, 06/2008, Volume 73, Issue 5-6, pp. I - VI
Journal Article
World Journal of Urology, ISSN 0724-4983, 2/2017, Volume 35, Issue 2, pp. 179 - 188
Journal Article